Middle East and Africa Immunohistochemistry Market to Grow at a CAGR of 6.3% to reach US$ 136.50 million from 2021 to 2028

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Middle East and Africa Immunohistochemistry Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Middle East and Africa Immunohistochemistry Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Rising Incidences of Chronic and Infectious Diseases
5.1.2 Increasing Geriatric Population
5.1.3 Increasing R&D Investments by Biotechnology & Biopharmaceutic mpanie

5.2 Market Opportunities

5.2.1 Development Opportunities in Emerging Countries

5.3 Future Trends

5.3.1 Increasing Acceptance of Automation in Immunohistochemistry

5.4 Impact of Drivers and Restraints

6. Middle East and Africa Immunohistochemistry Market Regional Analysis

6.1 Middle East and Africa Immunohistochemistry Market Overview

6.2 Middle East and Africa Immunohistochemistry Market Revenue 2019-2028 (US$ Million)

6.3 Middle East and Africa Immunohistochemistry Market Forecast Analysis

7. Middle East and Africa Immunohistochemistry Market Analysis – by Application

7.1 Diagnostics

7.1.1 Overview
7.1.2 Diagnostics: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Drug Testing

7.2.1 Overview
7.2.2 Drug Testing: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2031 (US$ Million)

8. Middle East and Africa Immunohistochemistry Market Analysis – by Product

8.1 Antibodies

8.1.1 Overview
8.1.2 Antibodies: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

8.2 Equipment

8.2.1 Overview
8.2.2 Equipment: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

8.3 Reagents

8.3.1 Overview
8.3.2 Reagents: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Kits

8.4.1 Overview
8.4.2 Kits: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

9. Middle East and Africa Immunohistochemistry Market Analysis – by End User

9.1 Hospitals and Diagnostic Laboratories

9.1.1 Overview
9.1.2 Kits: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

9.2 Research Institutes

9.2.1 Overview
9.2.2 Kits: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10. Middle East and Africa Immunohistochemistry Market – Middle East and Africa Analysis

10.1 Middle East and Africa

10.1.1 Middle East and Africa Immunohistochemistry Market Breakdown, by Key Country, 2022 and 2028 (%)
10.1.1.1 Middle East and Africa Immunohistochemistry Market – Revenue and Forecast Analysis – by Country
10.1.1.1 South Africa: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 South Africa: Middle East and Africa Immunohistochemistry Market Breakdown, by Application
10.1.1.1.2 South Africa: Middle East and Africa Immunohistochemistry Market Breakdown, by Product
10.1.1.1.3 South Africa: Middle East and Africa Immunohistochemistry Market Breakdown, by End User

10.1.1.2 Saudi Arabia: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Saudi Arabia: Middle East and Africa Immunohistochemistry Market Breakdown, by Application
10.1.1.2.2 Saudi Arabia: Middle East and Africa Immunohistochemistry Market Breakdown, by Product
10.1.1.2.3 Saudi Arabia: Middle East and Africa Immunohistochemistry Market Breakdown, by End User

10.1.1.3 UAE: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 UAE: Middle East and Africa Immunohistochemistry Market Breakdown, by Application
10.1.1.3.2 UAE: Middle East and Africa Immunohistochemistry Market Breakdown, by Product
10.1.1.3.3 UAE: Middle East and Africa Immunohistochemistry Market Breakdown, by End User

10.1.1.4 Rest of Middle East and Africa: Middle East and Africa Immunohistochemistry Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Rest of Middle East and Africa: Middle East and Africa Immunohistochemistry Market Breakdown, by Application
10.1.1.4.2 Rest of Middle East and Africa: Middle East and Africa Immunohistochemistry Market Breakdown, by Product
10.1.1.4.3 Rest of Middle East and Africa: Middle East and Africa Immunohistochemistry Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Middle East and Africa Immunohistochemistry Market Industry Landscape

12.1 Overview

12.2 Mergers and Acquisitions

12.3 Agreements, Collaborations, and Joint Ventures

12.4 New Product Launches

12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Abcam plc

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Agilent Technologies, Inc.

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bio SB

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 BIO-RAD LABORATORIES INC.

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Danaher

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 F. HOFFMANN-LA ROCHE LTD.

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 MERCK KGaA

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 PerkinElmer Inc.

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

13.9 THERMO FISHER SCIENTIFIC INC.

13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix

14.1 About Business Market Insights